You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 諾輝健康-B升4% 下週一正式摘“B” 獲高盛上調目標價至57.7港元
格隆匯3月16日丨諾輝健康-B升4.48%,報34.95港元,總市值160億港元。諾輝健康-B公佈,自今年3月20日(下週一)起,公司的中文及英文股份簡稱將不再加上標記“B”。此外,公司近日公佈,2022年實現營業收入7.7億元,較2021年同比增長259.5%;實現毛利潤6.5億元,較2021年同比增長318%。基於去年業績表現,高盛將其今明兩年銷售額預測上調3%及1%,並將2023至2025年盈利預測上調62%、21%及30%,以反映產品平均售價提升及銷售渠道組合優化推動毛利率增長,以及管理和研發費用比率降低所帶來的營運效率提升,目標價從55.9港元上調至57.7港元,評級“買入”。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account